REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Aventis Pharma S.A. (Peru)

Main Activities: Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing
Full name: Aventis Pharma S.A. Profile Updated: September 19, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Sanofi-Aventis is one of the major pharmaceutical companies worldwide. The Multinational arrived in Peru in November 1956, developing pharmaceutical products in seven therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine and vaccines.

Headquarters
Av. Victor Andres Belaunde 147 Edificio Real Uno Of. 802, San Isidro
Lima; Lima;

Contact Details: Purchase the Aventis Pharma S.A. report to view the information.

Website: http://www2.aventis.com/pharma/pharma.htm

Basic Information
Total Employees:
Purchase the Aventis Pharma S.A. report to view the information.
Outstanding Shares:
Purchase the Aventis Pharma S.A. report to view the information.
Registered Capital:
Purchase the Aventis Pharma S.A. report to view the information.
Incorporation Date:
January 07, 1955
Key Executives
Purchase this report to view the information.
President of the Board Directors
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Sales Director
Purchase this report to view the information.
Computer Manager
Ownership Details
Purchase this report to view the information.
52.24%
Purchase this report to view the information.
40%
Purchase this report to view the information.
5.47%
Company Performance
Financial values in the chart are available after Aventis Pharma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PEN. Absolute financial data is included in the purchased report.
Total operating revenue
29.9%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo